专利号:US-2017283878-A1 优先权日:2015-12-11 标题:Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers 发明人:WONG CHI-HUEY; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI; HSU TSUI-LING 权利人:ACADEMIA SINICA 摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta-4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for diagnostic and therapeutic uses.
专利号:US-5763625-A 优先权日:1995-04-25 标 题:Synthesis and use of β-lapachone analogs 发明人:BOOTHMAN DAVID A; FRYDMAN BENJAMIN J; WITIAK DONALD T 权利人:WISCONSIN ALUMNI RES FOUND 摘要:3-Substituted-β-lapachone analogs and their use either alone or to augment chemotherapy or radiotherapy to induce programmed neoplastic cell death without exhibiting toxicity to surrounding normal cells are disclosed. In particular, 3-allyl-β-lapachones, 3-alkyl-β-lapachones and 3-halo-β-lapachones were found to be Topoisomerase (Topo I) inhibitors. When these analogs are used alone there is a reversible single-strand break in the DNA of neoplastic cells causing apoptosis and cell death in some cells. However, when these analogs are combined with chemotherapy or X-irradiation, an irreversible Topo I-mediated break is achieved. A new and more efficient chemical synthesis of the compounds is also disclosed.
专利号:US-6458974-B1 优先权日:2001-01-25 标 题:Synthesis of β-lapachone and its intermediates 发明人:JIANG ZHIWEI; HOGELAND JANE 权利人:CYCLIS PHARMACEUTICALS INC 摘要:A novel process for synthesizing beta-lapachone (beta-lapachone), an agent that has demonstrated significant antineoplastic activity against human cancer lines. The process comprises the conversion of starting material, 2-hydroxy-1,4-naphothoquinone into beta-lapachone intermediate, lapachol. The lapachol is then converted to beta-lapachone by treatment with sulfuric acid and purified by recrystallization from ethanol. This novel process is extremely simple and provides beta-lapachone in excellent quality and high yield.
专利号:US-7790765-B2 优先权日:2007-04-30 标题:Hydroxy sulfonate of quinone compounds and their uses 发明人:BARTIS JUDIT; VOLCKOVA ERIKA; TANDON MANISH; LOWE DEIRDRE; REDMON MARTIN P 权利人:ARQULE INC 摘要:The present invention provides sodium 6-hydroxy-2,2-dimethyl-5-oxo-3,4,5,6-tetrahydro-2H-benzo(h)chromene-6-sulfonate, and its synthesis and uses in the treatment of cancer.
专利号:CA-2436125-C 优先权日:2001-01-25 标题 :Synthesis of beta-lapachone and its intermediates
专利号:CA-2436125-A1 优先权日:2001-01-25 标题 :Synthesis of beta-lapachone and its intermediates
1: Kim JH, Lee SM, Myung CH, Lee KR, Hyun SM, Lee JE, Park YS, Jeon SR, Park JI, Chang SE, Hwang JS. Melanogenesis inhibition of β-lapachone, a natural product from Tabebuia avellanedae, with effective in vivo lightening potency. Arch Dermatol Res. 2015 Feb 8. [Epub ahead of print] doi: 10.1038/cddis.2014.564. 3: Menacho-Márquez M, RodrÃguez-Hernández CJ, Villaronga MÃ
合成参考文献
参考文献:10.1007/978-1-61779-182-6_7 摘要:Iwamatsu T. Chromosome formation during fertilization in eggs of the teleost Oryzias latipes. Methods Mol Biol. 2011;761():97–124. doi: 10.1007/978-1-61779-182-6_7.